Summary
BTL Chart
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
The 'Goldilocks' Case For Baxter International
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance.
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Shafer - Chairman and Interim Chief Executive Officer Heather Knight - Chief Operating Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi David Roman - Goldman Sachs Travis Steed - BofA Securities Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan Larry Biegelsen - Wells Pito Chickering - Deutsche Bank Danielle Antalffy - UBS Operator Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material.
Baxter International Inc. Dividends
 BAX 4 days ago Announced | Quarterly | $0.17 Per Share |
| BAX 3 months ago Paid | Quarterly | $0.17 Per Share |
| BAX 6 months ago Paid | Quarterly | $0.17 Per Share |
| BAX 9 months ago Paid | Quarterly | $0.29 Per Share |
| BAX 31 May 2024 Paid | Quarterly | $0.29 Per Share |
Baxter International Inc. Earnings
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 13 Feb 2025 Date | | 0.52 Cons. EPS | 0.58 EPS |
| 6 Feb 2025 Date | | - Cons. EPS | - EPS |
| 8 Nov 2024 Date | | 0.78 Cons. EPS | 0.8 EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| BAX 4 days ago Announced | Quarterly | $0.17 Per Share |
| BAX 3 months ago Paid | Quarterly | $0.17 Per Share |
| BAX 6 months ago Paid | Quarterly | $0.17 Per Share |
| BAX 9 months ago Paid | Quarterly | $0.29 Per Share |
| BAX 31 May 2024 Paid | Quarterly | $0.29 Per Share |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 13 Feb 2025 Date | | 0.52 Cons. EPS | 0.58 EPS |
| 6 Feb 2025 Date | | - Cons. EPS | - EPS |
| 8 Nov 2024 Date | | 0.78 Cons. EPS | 0.8 EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
Baxter International Inc. (BTL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Baxter International Inc. ever had a stock split?
Baxter International Inc. Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Mr. David Brent Shafer CEO | XHAN Exchange | US0718131099 ISIN |
| US Country | 38,000 Employees | 28 Feb 2025 Last Dividend | 1 Jul 2015 Last Split | 27 Oct 1981 IPO Date |
Overview
Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.
Products and Services
- Sterile Intravenous (IV) Solutions
These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.
- Infusion Systems and Devices
Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.
- Parenteral Nutrition Therapies
Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.
- Generic Injectable Pharmaceuticals
The company supplies a range of generic injectables, including essential drugs for acute care settings.
- Surgical Hemostat and Sealant Products
These products are utilized to control bleeding and promote healing in surgical procedures.
- Advanced Surgical Equipment
Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.
- Smart Bed Systems
These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.
- Patient Monitoring and Diagnostic Technologies
Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.
- Respiratory Health Devices
Devices designed to assist with breathing disorders and respiratory health management.
- Dialysis Therapies and Services
Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.
- Adhesion Prevention Products
These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.
- Drug Compounding
Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.
- Inhaled Anesthesia
Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.
Contact Information
